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KAJIAN FITOKIMIA TYPHONIUM FLAGELLIFORME (LODD.) BLUME 
(ARACEAE) BERPANDUKAN AKTIVITI ANTIKANSER IN VITRO 
 
ABSTRAK 
 
 Typhonium flagelliforme (Lodd.) Blume merupakan sejenis tumbuhan 
tempatan yang digunakan sebagai ubat herba tradisional terhadap berbagai jenis 
penyakit kanser. Untuk mengetahui tindakan farmakologi, keselamatan dan 
keberkesanan tumbuhan herba ini dengan lebih terperinci, kandungan kimia dan 
kesan biologinya perlu dikenalpasti dan dicirikan terlebih dahulu. 
 Suatu kaedah pengekstrakan yang sesuai telah dipilih dengan teliti pada 
peringkat awal kajian ini. Tiga jenis kaedah pengekstrakan yang mempunyai cara 
tindakan yang berlainan, iaitu soxhlet, pengekstrakan yang dibantui ultrasonik dan 
rendaman telahpun dikaji. Kaedah rendaman merupakan kaedah pengekstrakan yang 
paling sesuai kerana ekstrak yang diperolehi adalah lebih aktif dan mempunyai 
kepelbagaian kandungan kimia yang tinggi, walaupun ia mempunyai peratusan hasil 
yang lebih rendah berbanding dengan kaedah-kaedah lain. Kajian juga menunjukkan 
bahawa pelarut-pelarut tidak polar seperti heksana dan diklorometana paling sesuai 
digunakan untuk mengekstrak sebatian-sebatian aktif dalam tumbuhan ini. 
 Tiga fraksi daripada ekstrak diklorometana, iaitu D/F19, D/F21 dan D/F15 
telah dikaji. D/F19 merupakan fraksi yang paling aktif terhadap turunan sel NCI-H23 
(kanser paru-paru manusia) tetapi ia juga didapati aktif terhadap turunan sel bukan 
kanser BALB/c 3T3. D/F21 merupakan fraksi yang kedua paling aktif dan 
mempunyai spesifikasi yang bagus terhadap NCI-H23 berbanding dengan BALB/c 
3T3. D/F15 merupakan fraksi utama Typhonium flagelliforme yang mempunyai 
 xxii 
kesan antiproliferat yang sederhana. Feoforbid-a dan pirofeoforbid-a merupakan dua 
sebatian utama yang dipencilkan daripada fraksi D/F19. Metil heksadekanoat, 1-
heksadekena, fitol dan suatu terbitan fitol merupakan kandungan kimia yang 
mungkin terdapat dalam D/F21. Kampesterol, stigmasterol, β-sitosterol, asid 
palmitik, asid oleik, asid linoleik dan asid linolenik merupakan kandungan kimia 
D/F15. 
 Kesan antiproliferat D/F19 didapati bukan dihasilkan oleh komponen tunggal 
tetapi adalah hasil tindakan sinergistik daripada campuran komponen-komponen. 
D/F19 megaruhkan kematian sel mengikuti laluan apoptosis. Di samping itu, D/F19 
juga didapati mempunyai kesan pengfotopekaan terhadap NCI-H23 dan suatu 
turunan sel payu dara manusia, HS578T, yang dihasilkan daripada aktiviti feoforbid-
a, pirofeoforbid-a dan suatu lagi subfraksinya, iaitu D/F19/04. Feoforbid-a dan 
pirofeoforbid-a merupakan agen pengfotopekaan cahaya yang telah dibuktikan 
berkesan secara in vitro dan in vivo untuk digunakan dalam terapi fotodinamik. 
Fraksi D/F21 didapati mempunyai aktiviti antiproliferat dan dapat mengaruhkan 
apoptosis. Kesan ini mungkin adalah disebabkan oleh aktiviti fitol. Walaupun 
kandungan kimia D/F15 merupakan sebatian-sebatian yang biasa ditemui dalam 
tumbuh-tumbuhan, sebatian-sebatian ini dipercayai dapat menyumbang kepada kesan 
rawatan Typhonium flagelliforme terhadap kanser berdasarkan kepada hasil-hasil 
penyelidikan lain yang telah dilaporkan. 
 Secara keseluruhan, kandungan kimia Typhonium flagelliforme yang 
mempunyai aktiviti antikanser secara in vitro telah berjaya dikenalpasti melalui 
pendekatan bioaktiviti berpandu. Kajian ini menyokong penggunaan Typhonium 
flagelliforme secara etnoperubatan terhadap kanser. 
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IN VITRO ANTICANCER ACTIVITY GUIDED INVESTIGATION OF THE 
PHYTOCHEMICALS OF TYPHONIUM FLAGELLIFORME (LODD.) 
BLUME (ARACEAE) 
 
ABSTRACT 
 
 Typhonium flagelliforme (Lodd.) Blume is an indigenous plant of Malaysia 
used as a traditional herbal medicine to treat various types of cancer. In order to 
effectively understand its pharmacological action, safety and efficacy, it is essential 
to firstly identify and characterise its chemical constituents and their biological 
relevance to the healing effect of the plant.  
 A suitable extraction methodology was carefully selected at the preliminary 
stage of this study. Three types of extraction methods with different modes of action, 
namely soxhlet, ultrasonic-assisted extraction and maceration methods were 
evaluated. The maceration method proved to be the most suitable extraction 
methodology for the purpose of this study with regard to the better activity and 
greater diversity of the chemical constituents obtained in the extract although the 
extraction yields were lower. The study also found that extraction carried out using 
non-polar solvents like hexane and dichloromethane is most suitable in obtaining the 
active chemical constituents. 
 Three fractions of the dichloromethane extracts, namely D/F19, D/F21 and 
D/F15 were evaluated. D/F19 was the most active fraction on NCI-H23 (human lung 
cancer) cell line but the fraction was also active on BALB/c 3T3 non-tumourous cell 
line. D/F21 was the second most active fraction with good specificity for NCI-H23 
as compared to BALB/c 3T3. D/F15 was the major fraction of Typhonium 
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flagelliforme with moderate antiproliferative effect on NCI-H23. Pheophorbide-a and 
pyropheophorbide-a were the two major constituents isolated from D/F19. Methyl 
hexadecanoate, 1-hexadecene, phytol and a derivative of phytol were tentatively 
suggested to be the constituents in D/F21. Campesterol, stigmasterol, β-sitosterol, 
palmitic acid, oleic acid, linoleic acid and linolenic acid were the chemical 
constituents of D/F15. 
 The antiproliferative effect of D/F19 did not originate from a single 
component but was due to synergistic action from a mixture of components. Cell 
death was induced by D/F19 via the apoptotic pathway. In addition, D/F19 was also 
found to possess photosensitizing effect on NCI-H23 and a breast cancer cell line, 
HS578T, mainly due to the activity of pheophorbide-a, pyropheophorbide-a and 
another of its subfraction, D/F19/04. Pheophorbide-a and pyropheophorbide-a are 
photosensitizers proven in vitro and in vivo to be effective for use in photodynamic 
therapy. Fraction D/F21 was found to be antiproliferative and apoptosis inducing. 
This effect may be due to the result of the activity of phytol. Although the chemical 
constituents of D/F15 were commonly found in plants, these compounds are believed 
to also contribute to the healing effect of Typhonium flagelliforme against cancer as 
supported by many reported studies. 
 In short, the chemical constituents of Typhonium flagelliforme which possess 
in vitro anticancer activity have been identified based on a bioactivity guided 
approach. The study supports the ethnomedical use of Typhonium flagelliforme as a 
herbal remedy towards cancer. 
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CHAPTER 1   
INTRODUCTION 
1.1 Medicines from Plants 
 Plants have formed the basis for treatment of diseases in traditional medicine 
for thousands of years. It is the oldest and most natural form of medicine even at the 
present time. The World Health Organisation (WHO) estimated that about 80% of 
the world’s inhabitants today still rely on plants as their primary source of medicine 
and health care agents (Farnsworth et al., 1985). Early drugs or so called ‘folk 
medicine’ took the form of crude drugs prepared as tinctures, teas, poultices, 
powders, infusions and inhalants (Geddes & Grosset, 2000). The drug discovery 
trend then evolved into the isolation of their active constituents such as codeine, 
aspirin, quinine and morphine of which some are still in use today (Ng, 2004). Out of 
119 chemical substances that were isolated as drugs, above 74 % were discovered as 
a direct result of chemical studies which focused on the isolation of active substances 
from plants used in traditional medicine (Farnsworth et al., 1985). However, despite 
the many successes of plants as a source of medicine, the process of drug discovery 
from natural products has been a historically slow process, and the traditional natural 
product extract libraries were not compatible with high-throughput screening (Koehn 
& Carter, 2005).  
 In the beginning of 1990s, with the advent of combinatorial chemistry, many 
big pharmaceutical companies switched their drug discovery strategies to include a 
large proportion of combinatorial chemistry (Balkenhohl et al., 1996). The ability of 
combinatorial chemistry to generate huge amount of compound libraries which 
would then undergo high-throughput screening to identify the lead compounds has 
been thought to be an efficient approach and thus carries great promise (Lee & 
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Breitenbucher, 2003). In addition, most of the synthetic compound libraries have no 
issues with intellectual property right and biodiversity conservation as those 
experienced with natural products (Baker et al., 1995; Fischli et al., 2002). However, 
by the mid to end of 1990s, results from the early combinatorial libraries had been a 
great disappointment with almost no lead compounds ever generated despite a few 
hits (Lahana, 1999). The inability of the synthetic libraries to generate lead 
compounds of biological relevance is mainly due to the different chemical space 
occupied by the synthetic compounds compared to natural products (Butler, 2004). 
Synthetic compounds have lower molecular weights, higher number of nitrogen, 
halogen and sulphur atoms but lower content of oxygen than natural products 
(Henkel et al., 1999). In addition, these compounds have less chiral centres, less 
complex structures and are greater in flexibility compared to natural products. 
Structural flexibility results in entropic losses that weaken the binding with protein 
molecules where the therapeutic effect is exerted (Feher & Schmidt, 2003). 
 In the present decade, there has been a renewed interest in natural product 
research due to the failure of other alternative drug discovery methods to produce 
lead compounds in key therapeutic areas particularly immunosuppresion, 
antiinfectives, anticancer and metabolic diseases (Butler, 2004). Although natural 
products isolated as the active compounds were sometimes not suitable for direct 
development into an effective drug, it can provide a suitable lead for conversion into 
clinically useful agents (Young, 1999; Hall et al., 2001). Some of the examples of 
new drugs derived from natural sources are apomorphine, which is a morphine 
derivative isolated from Papaver comniferum used to treat Parkinson’s disease; 
arteether, an antimalarial drug developed from artemisinin isolated from Artemisia 
annua; vinflunine, an improved anticancer agent derived from vinblastine isolated 
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from Catharanthus roseus; tiotropium, a derivative of atropine isolated from Atropa 
belladonna for the treatment of bronchospasm associated with chronic obstructive 
pulmonary disease and many others (Balunas & Kinghorn, 2005; Chin et al., 2006). 
Statistics have shown that among the drugs approved by FDA from 1981 to 2006, 
those of natural products origin contributed a substantial amount of 52 % (Cragg et 
al., 1997; Newman et al., 2003; Newman & Cragg, 2007) as shown in Figure 1.1. 
Thus this indicates that natural products still play an important and irreplaceable role 
as a source of modern pharmaceuticals. 
 
 
Figure 1.1: Drugs approved by FDA from Jan 1981 to June 2006 by source (total 
number of drugs, N = 1184). (Source: Newman & Cragg, 2007, p.472). 
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1.2 Plants as a Source of Anti-cancer Agents 
 According to the National Cancer Institute (NCI) of the United States, cancer 
is defined as ‘a disease in which abnormal cells divide without control and are able to 
invade other tissues’ (National Cancer Institute, 2009). This disease occurs mainly 
due to the mutation of certain genes that resulted in the disruption of cell growth 
regulation, repair of cell damage and growth inhibition (King & Robins, 2006). 
Human cancers can generally be classified into several categories. Carcinomas are 
malignant tumours that originated from epithelial tissues. Sarcoma refers to cancer 
that is mesenchymal in origin, such as the bone, cartilage, fat, muscle, blood vessels, 
or other connective or supportive tissue. Neoplasms of the hematopoietic system are 
termed leukemia if it originates from the blood forming tissue, or lymphoma if it 
begins from the cells in the immune system (Ruddon, 1995).  
 Cancer is one of the major diseases affecting mankind with approximately 
10.9 million people around the world diagnosed with cancer every year of which 
45% are from Asia (Ferlay et al., 2004). Mortality as a result of cancer is estimated to 
be 6.7 million per year, which is 12% of total deaths that occur annually (Ferlay et al., 
2004; Ma & Yu, 2006). In Malaysia, cancer is the fourth leading cause of death 
among the medically certified deaths with an annual incidence of 30,000 people (Lim, 
2002). It is estimated that out of four Malaysians, one is expected to get cancer in 
his/her lifetime. The most common cancers found among men are lung, nasopharynx, 
colon, leukaemia, rectum and prostate while in women the common types of cancer 
are breast, cervix, colon, ovary, leukaemia and lung (Lim et al., 2003).  
 The approaches to the treatment of cancer are surgery, radiotherapy, 
immunotherapy and chemotherapy. Surgery is usually the first choice of treatment 
with the goal to remove totally or at least reduce the mass of tumour. However, in 
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many cases, secondary tumours have established by the time the primary tumour is 
detected, thus chemotherapy and radiotherapy usually follow after surgery (King & 
Robins, 2006). Chemotherapy involves the use of cytotoxic or cytostatic drugs to kill 
or prevent malignant cells from proliferating (Cragg et al., 1996). The efficacy of the 
drug depends on the concentration of the drug that reaches the tumour, the duration 
of exposure and the proportion of the population that is proliferating. In many cases 
however, the action of chemotherapeutic drugs are not specific towards malignant 
cells alone but affects proliferating cells throughout the body and can be toxic to vital 
organs such as the heart and kidney, resulting in numerous untoward side effects. To 
minimise these unwanted effect, many chemotherapists use combinations of drugs 
which have additive effects against tumours but have less toxicities to normal cells 
(Boyer & Tannock, 1998). 
 Alkylating agents are drugs that act through covalent bonding of the alkyl 
groups to intracellular macromolecules. The formation of a positively charged 
intermediate compound combines with the electron-rich nucleophilic groups such as 
amino, phosphate, sulfhydryl or hydroxyl moiety that are present in the DNA, 
resulting in lethal toxicity to the cell. Examples of anticancer drugs in this category 
are such as the nitrogen mustards and nitrosoureas (Neidle & Thurston, 2005). 
 Antimetabolites are drugs that inhibit nucleic acid synthesis and prevent 
normal cell division from occurring. Examples of drugs in this category are 
methotrexate, 5-fluorouracil and cytosine arabinoside. These drugs are cell cycle-
specific and exert toxicity on other proliferating cells such as the bone marrow cells 
and gastrointestinal mucosa (Highley et al., 2009).  
 The third category of anticancer drugs is the natural products. It covers a 
substantial percentage of the total amount of anticancer drugs introduced in the time 
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frame of 1981–2006, whereby 77.8% were either natural products per se or derived 
from natural products (Newman & Cragg, 2007). There are four major classes of 
natural products based anticancer drugs which are derived from plants and these have 
quite diverse mechanism of actions. The first anticancer drugs of this category are 
the vinca alkaloids, vincristine and vinblastine, isolated from the Madagascar 
periwinkle, Caranthus roseus. These compounds block mitosis with metaphase arrest 
by binding specifically to tubulin resulting in its depolymerization (Okouneva et al., 
2003) and are useful for the treatment of leukaemia, lymphoma, breast and lung 
cancers (Cragg & Newman, 2005).  Another class of compounds which also affect 
the microtubules by causing tubular bundling are the taxanes, paclitaxel and 
docetaxel, extracted from pacific yew tree Taxus brevifolia (Hirose & Takiguchi, 
1995). Paclitaxel is used primarily for the treatment of breast, ovarian and non-small 
cell lung cancer (Wall & Wani, 1996). The epipodophyllotoxins, etoposide and 
teniposide, derived from the mandrake plant Podophyllum peltatum are DNA 
topoisomerase II inhibitors. These drugs are used against lymphoma, bronchial and 
testicular cancers (Gordaliza et al., 2004). Camptothecin is a selective inhibitor of 
topoisomerase I which was isolated from the stem bark of the Chinese tree 
Camptotheca acuminate. It is used against breast, lung and colorectal cancers (Wall 
& Wani, 1996). Many other drugs which are derived from these four major classes of 
compounds are currently under clinical trials (Balunas & Kinghorn, 2005). The 
chemical structures of some of the anticancer agents derived from plants are given in 
Figure 1.2. 
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Figure 1.2: Anticancer agents derived from plants. 
 
 There are approximately 250,000 plant species distributed throughout the 
world and more than half of these are found in the tropical rainforests (Wilson, 1988). 
Vinblastine: R = CH3 
Vincristine: R = CHO 
O NH
O
O
OH
O
O
O
H
OO
O
O
OH
O
OH
O
O NH
O
O
OH
O
O
O
H
OO
O
O
OH
O
OH
N
H
N
OH
O
O
N
N
H
OH
O
O
R
O
H
O
O
Paclitaxel 
Docetaxel 
N
N
O
O
OH O
Campthothecin 
O
O
O
OH
O O
O
O
O
O
O
OH
HO
H
O
O
O
OH
O O
O
O
O
O
O
OH
HO
S
Etoposide Teniposide 
8 
So far, only 1% of tropical species have been explored for their pharmaceutical 
potentials and there remain a substantial opportunity for finding more new 
compounds of pharmaceutical interests (Zuhud, 1991; Fakim, 2006). The vast variety 
of flora and fauna hosted by the tropical rainforests provide natural product chemists 
with numerous compounds as starting point for the development of new anticancer 
drugs.  
 Malaysia is home to about 40,000 species of higher plants of which about 
36,000 are flowering plants, 3,600 are ferns and 87 are conifers (Soepadmo, 1998). 
In addition to the magnificent array of plant species, Malaysia has a unique 
confluence of traditional medicine system due to the diverse ethnic communities in 
the country. The rich ethnobotanical and ethnopharmacological knowledge in the use 
of plants has provided a good starting point for Malaysian scientists for locating 
useful tropical plants for phytochemical investigation. To make use of these 
advantages, the present study selected Typhonium flagelliforme as the subject of 
study since it has been used locally as an alternative treatment for cancer but has not 
been investigated in depth scientifically.  
 
1.3 Typhonium flagelliforme (Lodd.) Blume 
1.3.1 Taxonomy and Distribution 
 Typhonium flagelliforme (Lodd.) Blume is a herbal plant indigenous to 
Malaysia which belongs to the family of Araceae under the subfamily of Aroid. The 
tuber of the plant is nearly round and measures about 1 cm in diameter. The leaves 
are green and smooth, typically narrowly hastate with spreading basal lobes but may 
be elliptic sometimes. The size of the blade is about 6 × 4 cm.  The petiole is 
yellowish and thin, it measures about 6–20 cm long, partially enclosed in the spathe. 
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The colour of the spathe is green with brownish margin, the limb is linear acute, 
dilated and round at the base. The flowers are unisexual (Hsuan et al., 1998; 
Nicolson & Sivadasan, 1981). A picture of Typhonium flagelliforme is given in 
Figure 1.3. 
 
 
Figure 1.3: Picture of Typhonium flagelliforme.  
  
 Typhonium flagelliforme, which was previously mistakenly regarded as 
Typhonium divaricatum, is distributed across IndoChina, Peninsular Malaysia, 
Northern Queensland, South India, Sri Lanka and Luzon as shown in Figure 1.4 
(Nicolson & Sivadasan, 1981). It grows wild in waste grounds and is native to 
several parts of Peninsular Malaysia such as the ditches in Melaka town and the 
Sepoy lines in Penang (Ridley, 1967). However, due to developments and 
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deforestations, these plants are no longer found in the mentioned areas but are mostly 
cultivated in pots and garden yards for personal consumption.  
 
 
Figure 1.4: Geographical distribution of Typhonium flagelliforme (Source: Nicolson 
& Sivadasan, 1981, p.491). 
 
1.3.2 Ethnomedical Background 
 Typhonium flagelliforme, known by its vernacular name of Keladi Tikus 
(Malay) or Rodent Tuber (English), is described as toxic, warming and phlegm-
resolving in the Malaysian Traditional Chinese Medicine. The leaves or whole plant 
is often applied over swellings and used against various kinds of malignancy. The 
roots are used to eliminate expectoration (Lee & Wong, 2004). There have been 
many accounts on the uses of Typhonium flagelliforme for treating cancer, including 
colon, breast, prostrate, liver, lung and bone cancer. Many cancer patients who have 
tried such alternative therapy have claimed successes while others who took this 
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during the course of chemotherapy have experienced significant improvement in 
appetite, reduction in hair loss with no cases of nausea and vomiting (Teo & Ch’ng, 
1999). 
 The use of three other species of Typhonium has also been documented in the 
Traditional Chinese Medicine and Ayurvedic system for the treatment of cancer. In 
China, the tuber of Typhonium giganteum, the major component of Herbal Medicine 
Rhizoma Typhonii is applied externally in the form of paste to the lesion for the 
treatment of reticulocytic sarcoma and lymphoma (Chang, 1992). In India, the 
poultice of Typhonium trilobatum is used to treate Scirrhous tumours and cancerous 
tumours, while Typhonium orixense is used by the Indians and Pakistanis to treat 
Scirrhous tumours (Hartwell, 1982). 
 Each preparation of Typhonium flagelliforme requires the use of 
approximately 50 g of the fresh whole plant. The plant is pounded briefly using a 
mortar and pestle to break the cell walls and the juice is then forced out through a 
thin cloth. The juice extract is then mixed with honey in order to prevent irritation to 
the throat and is recommended to be consumed immediately. Initially, the juice is to 
be drunk 3 times daily and can be reduced to a maintenance dose of twice a week if 
improvement is observed. This can either be used as a single therapy or taken while 
undergoing the course of chemotherapy or radiotherapy (Neoh, 1992; Teo & Ch’ng, 
1999). There are also other less commonly used preparative methods of Typhonium 
flagelliforme, such as wrapping 2–6 pieces of the plant leaves in Longan flesh for 
direct consumption (Lee & Wong, 2004) and pulverising the dried plant material to 
prepare as a drink which is not documented. Of late, encapsulated dried plant powder 
of the plant is also available commercially (Global Bioscience, 2007). 
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1.3.3 Pharmacological Studies 
 In vitro studies carried out on the various extracts of Typhonium flagelliforme 
(then wrongly referred as Typhonium divaricatum (Nicolson & Sivadasan, 1981) 
revealed that the hexane, chloroform (CHCl3) and ethyl acetate (EtOAc) extracts 
exhibited significant cytotoxic effect on a murine lymphoid cell line with the rate of 
inhibition above 90%. However, the concentration of the extract tested and the cell 
line designation was not specified (Neoh, 1992). Choo et al. (2001a) had also 
observed cytotoxic activity for the hexane and CHCl3 extracts on P388 leukemia 
cells and the IC50s were found to be 15 µg/ml and 6 µg/ml respectively for the root 
extracts, 65 µg/ml and 8 µg/ml respectively for the stems/leaves extracts. Chan et al. 
(2005) also found the hexane, CHCl3 and n-butanol (n-BuOH) extracts to be active 
towards NCI-H23 human lung cancer cell line at IC50 1.8, 5.2 and 1.2 µg/ml, 
respectively, and T-47D human breast cancer cell lines at IC50 12.2, 23.0 and 54.6 
µg/ml, respectively. 
 A study on the effect of T. flagelliforme on the immune system of cat fish 
found that the plant, given as intraperitoneal injections, was able to increase 
phagocytic activity and other non-specific immune response. Resistance of the cat 
fish against live Vibrio parahaemolyticus was also found to have increased (Lam, 
1998). Another in vivo study conducted in rats showed that T. flagelliforme juice 
extract had a similar effect as glycyrrhizin in preventing hepatocarcinogenesis 
(Karuppiah et al., 1999). Other pharmacological studies also showed that the water, 
alcohol and ester extracts of Typhonium flagelliforme is antiasthmatic, 
antiinflamatory, analgesic, sedative, antiexpectoration and cough relieving (Zhong et 
al., 2001). 
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1.3.4 Phytochemicals  
 Chen et al. (1997) reported the isolation of benzenetridecanoic acid (synonym: 
13-phenyltridecanoic acid) and methyl benzenetridecanoate (synonym: methyl 13-
phenyltridecanoate) from the ethyl acetate extract of Typhonium flagelliforme. Four 
other esters, namely methyl hexadecanoate, methyl octadecanoate, methyl 9-
octadecenoate and methyl 9, 12-octadecadienoate were also identified by Choo et al. 
(2001b) from the hexane extract of Typhonium flagelliforme in addition to methyl 
13-phenyltridecanoate. However, despite the earlier report by Choo et al. (2001a) 
which showed that the CHCl3 extracts were more active than the hexane extracts, no 
study was carried out on the CHCl3 extracts. Huang et al. (2004a,b) had isolated 
several glycosides, namely coniferin, methylconiferin, 12-hydroxy-N-(3-hydroxy-1-
O-β-glucopyranosyloctadeca-4E,8E-dienyl)octadecanamide and two sterols, β-
sitosterol and β-daucosterol from the n-BuOH fraction of Typhonium flagelliforme. 
The chemical structures of the constituents are illustrated in Figure 1.5. Except for 
methyl 13-phenyltridecanoate that was found to be inactive in vitro, none of the 
chemical constituents had been tested for anticancer activity in the studies mentioned 
and none was used to support its ethnopharmacological application against cancer. 
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Figure 1.5: Chemical structures of the compounds isolated from Typhonium 
flagelliforme. 
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1.4 Methods of Plant Extraction 
 Extraction can be carried out on either fresh or dried plants. Ideally, fresh 
plant tissues should be used for phytochemical investigation right after collection 
(Harborne, 1998). However, if extraction is to be carried out a few days after 
collection, it should be stored dry in a plastic bag (Harborne, 1998). Alternatively, 
dried plants can also be used and has several advantages. Unlike in the case of fresh 
plant, solubility of the chemical constituents in the dried plants is not affected by the 
presence of water. It is also easier to handle when large scale extraction is carried out 
due to the lower mass to plant ratio (Eloff, 1998). However, when dried plant is 
intended for use, the material needs to be dried rapidly to prevent degradation of the 
components by air or microorganisms. If a vacuum system is used for drying, care 
should be taken in order to avoid excessive loss of the volatile constituents which 
may possess interesting biological activity (Fakim, 2006). 
 Nowadays, many extraction methods are available. The more commonly used 
methods are such as cold extraction, hot percolation, soxhlet, supercritical fluid 
extraction, ultrasonic-assisted solvent extraction and pressurized liquid extraction 
(Péres et al., 2006; Barnes et al., 2009). However, careful selection of the right 
extraction methodology is needed so that it is adaptable to the intended study (Fakim, 
2006). The improper extraction methods may result in degradation and loss of 
bioactive natural products which seriously hampers the outcome of the study (Davey 
et al., 2009). Three common and inexpensive extraction methodologies that were 
evaluated in this study are briefly introduced in the following sections. 
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1.4.1 Maceration 
 The maceration method is the simplest but yet still widely used procedure. 
Pulverised plant material is allowed to soak in solvents of differing polarity in a 
closed container at room temperature (Fakim, 2006). The metabolites are allowed to 
diffuse into the solvent and the period of extraction may differ from few hours to 
several weeks. Occasional or constant stirring is used sometimes to speed up the 
extraction. The disadvantage of this method is that it consumes large volumes of 
solvents and some of the poorly soluble metabolites may not be extracted efficiently 
since extraction is carried out at room temperature (Seidel, 2006). 
 
1.4.2 Soxhlet Extraction 
 Soxhlet extraction is a classical and most widely used extraction method. 
Pulverised plant material is placed in a cellulose thimble in an extraction chamber 
which is located above a collecting flask but beneath a reflux condenser. A suitable 
solvent is then added into the soxhlet apparatus and the solvent is heated to a boil. 
The solvent vapour rises and condenses into the thimble. When the thimble is filled 
with the solvent, it is siphoned back into the distillation flask and the whole cycle is 
then repeated (Pavia et al., 1995). The main advantage of Soxhlet extraction is that 
the solvent, when saturated with solubilized metabolites, is emptied into the 
distillation flask and fresh solvent is recondensed into the extraction thimble 
continuously, thus making the extraction procedure more efficient and solvent saving. 
However, the major disadvantage of this method is that the extraction carried out at 
high temperature may degrade thermolabile compounds and initiate the formation of 
artefacts (Seidel, 2006). 
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1.4.3 Ultrasonic-assisted Solvent Extraction 
 The ultrasonic-assisted solvent extraction is a technique modified from the 
maceration method. This solvent extraction method is facilitated by the use of 
ultrasound (frequency pulses approximately 20 kHz) and is one of the well 
established and commonly used methods today for extracting plant materials for 
bioactive principles (Sališová et al., 1997; Trusheva et al., 2007). The pulverised 
plant material is soaked in a suitable solvent in a container and ultrasound is used to 
induce mechanical stress on the plant which results in the formation of cavitations in 
the sample. The cellular breakdown allows easier access of the solvent into the cells 
thereby increases the solubility of the metabolites in the solvent. In addition the 
ultrasound also facilitates mass transfer and thus is a more efficient method of 
extraction (Vinatoru et al., 1997). However, the huge amount of energy generated 
increases extraction temperature and thus a cooling system is required in order to 
control the temperature. 
 
1.5 Techniques of Separation  
1.5.1 Thin-layer Chromatography  
Thin-layer chromatography (TLC) is a simple, cheap and quick method for 
analysis and screening of natural products. Thin layers of adsorbents, usually silica 
gel or alumina, is coated on glass, plastic and aluminium sheets. The TLC sheets can 
be cut into strips of various sizes according to the desire of the user. A mixture of 
natural products is then spotted near the bottom of the thin strip and developed in a 
jar that contains saturated atmosphere of the eluting solvent. The eluting strength of 
the solvent is varied by mixing two or more solvents with different polarity. As the 
mobile phase moves up the plate through capillary action, the components of the 
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mixture are carried along at different rates and hence separate from one another. The 
development of the plate is complete when the solvent front has advanced nearly to 
the top of the plate. The separated compounds on the TLC plate can be detected by 
ultraviolet (UV) illumination or spray with suitable detection reagent. TLC is 
frequently used to determine the optimal combinations of solvent for preparative 
column chromatography separations and to monitor the progress of separation by 
column chromatography (Gilbert & Martin, 1998). 
Preparative thin-layer chromatography (prep-TLC) is a scaled up procedure 
of TLC and is used to separate compound mixtures at a larger scale. Prep-TLC is 
normally used as a final purification step in compound isolation, most frequently 
after column chromatography. The chromatographic conditions for prep-TLC can be 
predetermined using a TLC plate by trial and error experimentation and then scale up 
in proportion using a similar or slightly less polar solvent combination. The separated 
compounds are either detected by the non-destructive UV method or by using a spray 
reagent.  When using a reagent, only a small section at the edge of the plate is 
sprayed, and the unreacted section of a particular separation band is scraped from the 
plate and desorbed from the silica sorbent using an appropriate solvent that is able to 
dissolve the compound (Gibbons, 2006). 
 
1.5.2 Column Chromatography 
 Column chromatography plays a very important role in the separation of 
compounds from a complex mixture of natural products. The principle of separation 
takes place through selective distribution of the components between the mobile 
phase, which is the eluting solvent, and the stationary phase, which is usually the 
silica gel. Different compounds have different adsorption affinities for the surface of 
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the stationary phase and the extent of adsorption is governed by the types of 
interaction between the compound molecule and the stationary phase such as 
hydrogen bonding, Van der Waals forces, dipole-dipole interactions, acid-base 
properties and others (Gilbert & Martin, 1998). The column can be developed using 
various eluting techniques such as gravity, application of nitrogen pressure at the 
inlet, vacuum suction or controlled by a pump. A solvent gradient is applied for 
separation of complex mixtures of compounds where the composition of the solvents 
is varied in steps so as to gradually increase the eluting strength of the mobile phase. 
The different rate of movement of the chemical constituents along the column then 
results in the separation of the compound mixture (Reid & Sarker, 2006). However, 
for a complex mixture of natural products such as crude extracts, compounds with 
similar polarity often co-elute in the same fraction and thus, chromatography may be 
carried out several times using different chromatographic conditions in order to 
obtain reasonably pure compounds. 
 Nowadays, the use of flash column chromatography has largely replaced 
classic column chromatography techniques. Flash column chromatography is an air 
pressure driven column chromatography which has been optimized for rapid 
separations. The smaller particle size of the silica gel and rapid flow rate was able to 
overcome poor separation recovery which is a problem faced in classic column 
chromatography due to band tailing (Landgrebe, 1993). In addition, the technique is 
inexpensive, easy to operate and allows separation of samples weighing between 
0.01–10.0 g in a short period of time (Still et al., 1978). This method is currently a 
preferred technique for routine large scale purification of natural products. 
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1.5.3 High Performance Liquid Chromatography  
 High performance liquid chromatography (HPLC) is a modern day analytical 
technique derived from the same working principle as for column chromatography. 
Compared to classical column chromatography, HPLC offers major advantages in 
convenience, speed, accuracy, selectivity and the ability to carry out difficult 
separations owing to the improvements in equipment sophistication, material, 
technique and the application of theory (Rouessac & Rouessac, 2007). The general 
setup of a HPLC system consists of a high-pressure pump, an injection port, a 
column which is the stationary phase, and a detector. The sample is introduced into 
the injection port and is carried by the stream of mobile phase delivered by the pump 
which then passes through the column where the separation takes place. Separation is 
then monitored with a detector.  
 Two modes of adsorption chromatography are available in HPLC, i.e. 
normal-phase and reversed-phase chromatography. Reversed-phase HPLC is 
generally preferred by many researchers as it is applicable to a wide range of 
chemical compounds. This mode of separation utilises the combination of a non-
polar stationary phase and a polar mobile phase which is usually a combination of 
acetonitrile and/or methanol with an aqueous solution. Acids, bases or buffers are 
frequently used as the aqueous solution with the purpose of suppressing compound 
ionisation and to control the degree of ionisation of free unreacted silanol groups in 
the column that can result in peak tailing which in turn affect the separation (Snyder 
& Kirkland, 1979). 
 For a long time the size of the HPLC column have been standardised around 
the internal diameter of 3–4.6 mm, which requires a mobile phase flow rate of 0.5–2 
ml/min. However, a wide choice of column now exists such as narrow-bore (2–4 mm 
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i.d.), microbore (1–2 mm i.d.) and even packed capillaries (<1 mm), for which the 
flow rate descends to a few µl/min and thus requires special pumps and detectors. 
Such developments were necessary as there has been increased demand for the 
determination of analyte at trace level concentrations over the recent years (Rouessac 
& Rouessac, 2007). Ultra high-performance liquid chromatography with the trade 
name of UPLC (Waters) or UHPLC (Agilent) is an improved version of HPLC. With 
the UPLC or UHPLC pump capable of operating at extremely high pressure limit, 
the system is designed to be used with sub-2 µm particle columns leading to 
exceptionally better resolution, sensitivity and separation speed due to the much 
improved column efficiency. Furthermore, when the system is integrated with a mass 
spectrometer, often termed as ‘hyphenation’, it allows provisional identification of an 
unknown natural product sample, thus further expand the potential and versatility of 
the analytical instrument (Niessen, 1999).  
 While an analytical HPLC is used for qualitative and quantitative 
determination of a compound, a preparative HPLC (prep-HPLC) is meant for 
isolation and purification of a compound. Purification of natural products using prep-
HPLC has been widely adopted by many synthetic and natural product chemists to 
date as the demand for higher throughput could be better met in an automated prep-
HPLC system. Moreover, the reproducibility, efficiency and consistency in 
compound separation are better in prep-HPLC compared to conventional column 
chromatography. Depending on the amount of sample intended to be purified, a wide 
range of prep-HPLC columns are available to cater for sample from µg scale up to kg 
level (Huber & Majors, 2004). 
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1.6 Compound Identification and Structure Elucidation 
1.6.1 Ultraviolet-visible Spectroscopy 
 Natural products absorb light in the ultraviolet or visible (UV-Vis) region of 
the electromagnetic spectrum. Absorption of the UV-Vis light occurs when the 
energy of the incident radiation is the same as the electronic excitation of the 
molecule (Lambert et al., 1976). An unknown natural product can be identified 
according to the complexity of its spectrum and the general position of the 
wavelength maxima. Different classes of compounds have their characteristic light 
absorption spectra and the identification of the class of compounds can be enhanced 
by performing measurements on the sample solution at different pH or in the 
presence of a particular inorganic salt and then observing the shift of the absorption 
band (Harborne, 1998). 
 
1.6.2 Infrared Spectroscopy 
Infrared (IR) radiation is the part of electromagnetic spectrum in between the 
visible and microwave regions. The portion which is of greatest practical use for a 
natural product chemist is the mid-IR region, which ranges from 4000 – 400 cm-1. A 
molecule that possesses an oscillating dipole absorbs energy from the oscillating 
electric field of a beam of infrared radiation when the IR frequency of the applied 
electric field is similar to the frequency of the oscillating dipole. Except for 
homonuclear diatomics, practically all molecules have some vibrations that produce 
a change of dipole moment (Lambert et al., 1976). The wavelength of absorption 
depends on the relative masses of the atoms, the force constants of the bonds 
between the atoms and the geometry of the atoms (Silverstein, et al., 2005). 
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A mid-IR spectrum can generally be evaluated in two parts. The region 
between 4000 – 1300 cm-1 is called the functional group region where characteristic 
stretching frequencies for important functional groups, such as O-H, N-H, C-H, C=O 
and C=C, are observed. The region between 1300–900 cm-1 is referred to as the 
“fingerprint” region where the complex absorption bands originated from interacting 
vibrational modes. Absorption at this region is unique for every type of molecule and 
can be used to cross examine the types of vibration in reference to the other regions. 
Due to its simplicity and reliability in identifying the functional groups, IR 
spectroscopy is an extremely useful method of assigning a compound to its class 
(Silverstein et al., 2005; Harborne, 1998). 
 
1.6.3 Nuclear Magnetic Resonance Spectroscopy 
 Nuclear Magnetic Resonance (NMR) Spectroscopy is practically an 
indispensable tool used for the identification and structure elucidation of natural 
products. Akin to IR and UV spectroscopy, it is another form of absorption 
spectroscopy that takes place in the radio frequency region. All nuclei are charged 
particles and some in addition have spin angular momentum. The nuclei of interest 
are those that have appropriate spin properties (spin quantum number, I ≠ 0) and 
generate a magnetic field. 1H and 13C nuclei (both having I = ½) have the widest 
application for identification of organic molecules.  
 In the presence of an external magnetic field, a spinning nucleus absorbs 
radiofrequency radiation, which has a magnitude that is identical to the Larmor 
frequency, resulting in nuclear transition to a higher energy spin state (Silverstein et 
al., 2005). However, a nucleus within a molecule experiences a lesser magnetic field 
than the applied external field. This phenomenon is due to the presence of electron 
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cloud around the nucleus which generates an induced magnetic field opposed to the 
external field termed as the “shielding effect”. The density of the shielding varies 
with the chemical environment of the nucleus and the variation gives rise to 
differences in chemical shift positions and the ability to distinguish among individual 
absorptions, hence the usefulness of NMR spectroscopy (Macomber, 1998). 
Chemical shift is measured relative to a reference compound, which is usually 
tetramethylsilane (TMS). 
 Based on a 1H NMR spectrum, the relative positions of the various types of 
protons in a molecule can be determined by evaluation of its chemical shifts, spin-
spin couplings and peak integral. Similarly, a 13C NMR spectrum provides 
information on the relative positions of various types of carbons in a molecule. Due 
to the low abundance of 13C nucleus and high abundance of 1H nucleus in nature as 
well as the large C-H coupling constants, a proton-coupled carbon spectrum usually 
shows complex overlapping multiplets which are difficult to interpret. Thus, for 
routine analysis of sample, a broadband proton-decoupled 13C spectrum is frequently 
used, where each type of carbon nucleus is represented by a single peak, making the 
interpretation much simpler (Silverstein et al., 2005). Distortionless enhancement by 
population transfer (DEPT) 13C NMR displays separate subspectra for CH, CH2 and 
CH3 carbon signals. Three types of DEPT experiments using three different pulse 
angles, θ, at 45°, 90° and 135° are available. A combination of DEPT experiments 
helps distinguish the types of protonated carbons. Any remaining carbon signal in the 
normal 13C spectrum which is not present in the DEPT subspectra would belong to 
the quaternary carbons (Macomber, 1998). 
 Two-dimensional (2D) NMR spectroscopy is also referred to as correlation 
spectroscopy where the correlation between two or more types of the same or 
